Andrew Ross NAGER,Spencer PARK,Javier Fernando CHAPARRO RIGGERS,Regina Junhui LIN,Thomas John VAN BLARCOM
申请号:
US16290388
公开号:
US20190292533A1
申请日:
2019.03.01
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention provides inducible chimeric cytokine receptors responsive to a ligand, e.g., a small molecule or protein, uses of such receptors for improving the functional activities of genetically modified immune cells, such as T cells, comprising the inducible chimeric cytokine receptors, and compositions comprising such cells.